Agilent Technologies - A Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $157.00
  • Forecasted Upside: 0.46 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
$156.28
▲ +2.55 (1.66%)

This chart shows the closing price for A by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Agilent Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for A and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for A

Analyst Price Target is $157.00
▲ +0.46% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Agilent Technologies in the last 3 months. The average price target is $157.00, with a high forecast of $170.00 and a low forecast of $139.00. The average price target represents a 0.46% upside from the last price of $156.28.

This chart shows the closing price for A for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 13 contributing investment analysts is to buy stock in Agilent Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/15/2021
  • 0 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/13/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/12/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/12/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/10/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/8/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/7/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/7/2022

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/22/2022CowenBoost Target$160.00 ➝ $168.00Low
11/22/2022Jefferies Financial GroupBoost Target$158.00 ➝ $168.00Low
11/22/2022Evercore ISIBoost Target$140.00 ➝ $155.00Low
11/22/2022CowenBoost Target$160.00 ➝ $168.00Low
11/22/2022Wells Fargo & CompanyBoost Target$135.00 ➝ $150.00Low
11/22/2022Robert W. BairdBoost Target$160.00 ➝ $170.00Low
11/22/2022CitigroupBoost TargetNeutral$145.00 ➝ $150.00Low
11/22/2022SVB LeerinkBoost TargetOutperform$145.00 ➝ $160.00Low
11/22/2022KeyCorpBoost TargetOverweight$155.00 ➝ $165.00Low
8/24/2022Credit Suisse GroupInitiated CoverageOutperform$165.00Low
8/22/2022Evercore ISIBoost Target$145.00Low
8/22/2022CowenBoost Target$160.00Low
8/17/2022Bank of AmericaBoost TargetBuy$148.00 ➝ $155.00Low
8/17/2022Wells Fargo & CompanyBoost TargetEqual Weight$130.00 ➝ $135.00Low
8/17/2022CitigroupBoost TargetNeutral$140.00 ➝ $145.00Low
8/17/2022Robert W. BairdBoost TargetOutperform$155.00 ➝ $160.00Low
7/20/2022UBS GroupInitiated CoverageBuy$139.00Low
7/14/2022The Goldman Sachs GroupLower TargetBuy$170.00 ➝ $140.00Low
7/8/2022CitigroupDowngradeBuy ➝ Neutral$175.00 ➝ $140.00N/A
6/2/2022KeyCorpLower TargetOverweight$195.00 ➝ $155.00High
5/26/2022The Goldman Sachs GroupReiterated RatingBuy$170.00Low
5/25/2022Robert W. BairdBoost TargetOutperform$155.00 ➝ $161.00High
4/25/2022Wells Fargo & CompanyLower TargetOverweight ➝ Equal Weight$160.00 ➝ $130.00Medium
4/19/2022Truist FinancialDowngradeBuy ➝ HoldMedium
2/23/2022Evercore ISILower TargetOutperform$170.00 ➝ $155.00High
2/23/2022Bank of AmericaLower TargetBuy$179.00 ➝ $160.00High
2/23/2022CowenLower TargetOutperform$187.00 ➝ $178.00High
2/23/2022Stifel NicolausLower TargetHold$169.00 ➝ $145.00High
2/23/2022Wells Fargo & CompanyLower TargetOverweight$180.00 ➝ $160.00High
2/23/2022Robert W. BairdLower Target$170.00 ➝ $161.00High
2/23/2022CitigroupLower TargetBuy$190.00 ➝ $175.00High
2/23/2022SVB LeerinkLower TargetOutperform$175.00 ➝ $145.00High
11/23/2021CowenBoost TargetHold ➝ Outperform$180.00 ➝ $187.00High
11/23/2021Stifel NicolausBoost TargetHold$162.00 ➝ $169.00High
11/23/2021Bank of AmericaBoost TargetBuy$177.00 ➝ $179.00High
11/23/2021SVB LeerinkBoost TargetOutperform$170.00 ➝ $175.00Low
10/14/2021CowenLower TargetOutperform$200.00 ➝ $180.00Low
9/17/2021CowenBoost TargetOutperform$165.00 ➝ $200.00Low
8/18/2021CowenBoost TargetOutperform$150.00 ➝ $165.00Medium
8/18/2021Jefferies Financial GroupBoost TargetBuy$155.00 ➝ $185.00Medium
8/18/2021Wells Fargo & CompanyBoost TargetOverweight$150.00 ➝ $180.00Medium
8/18/2021SVB LeerinkBoost TargetOutperform$160.00 ➝ $170.00Medium
8/18/2021KeyCorpBoost TargetPositive ➝ Overweight$160.00 ➝ $195.00Medium
8/18/2021Stifel NicolausBoost TargetHold$136.00 ➝ $162.00Low
8/18/2021Robert W. BairdBoost TargetOutperform$144.00 ➝ $170.00Low
8/18/2021CitigroupBoost TargetBuy$160.00 ➝ $190.00Low
7/12/2021KeyCorpBoost TargetOverweight$157.00 ➝ $160.00Low
6/22/2021Societe GeneraleUpgradeHold ➝ BuyLow
5/26/2021KeyCorpBoost TargetOverweight$148.00 ➝ $157.00High
5/26/2021SVB LeerinkBoost TargetOutperform$140.00 ➝ $145.00High
5/26/2021Wells Fargo & CompanyBoost TargetOverweight$140.00 ➝ $150.00High
5/26/2021Robert W. BairdBoost TargetOutperform$137.00 ➝ $144.00High
5/26/2021CitigroupBoost TargetBuy$150.00 ➝ $160.00High
3/19/2021Redburn PartnersUpgradeNeutral ➝ BuyLow
3/18/2021CitigroupUpgradeNeutral ➝ Buy$150.00Medium
2/17/2021KeyCorpBoost Target$130.00 ➝ $148.00Low
2/17/2021CitigroupBoost Target$120.00 ➝ $135.00Low
2/17/2021Robert W. BairdBoost TargetOutperform$133.00 ➝ $137.00Low
2/17/2021Wells Fargo & CompanyBoost TargetOverweight$120.00 ➝ $140.00Low
2/17/2021CowenBoost TargetOutperform$125.00 ➝ $135.00Low
2/17/2021SVB LeerinkBoost TargetOutperform$130.00 ➝ $140.00Low
2/17/2021Bank of AmericaUpgradeNeutral ➝ Buy$147.00Low
1/12/2021MizuhoInitiated CoverageBuy$51.00Medium
12/23/2020MKM PartnersInitiated CoverageBuy$57.00N/A
12/15/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$49.00Low
12/10/2020SVB LeerinkBoost TargetOutperform$120.00 ➝ $130.00High
12/3/2020Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformLow
12/2/2020The Goldman Sachs GroupInitiated CoverageBuy$130.00Low
11/25/2020UBS GroupUpgradeNeutral ➝ Buy$103.00 ➝ $132.00Low
11/24/2020JPMorgan Chase & Co.Boost TargetOverweight$110.00 ➝ $125.00High
11/24/2020Wells Fargo & CompanyBoost TargetOverweight$105.00 ➝ $120.00High
11/24/2020Robert W. BairdBoost TargetOutperform$104.00 ➝ $118.00High
11/24/2020SVB LeerinkBoost TargetOutperform$100.00 ➝ $120.00High
11/9/2020KeyCorpInitiated CoverageOverweight$130.00High
11/9/2020HSBCUpgradeHold ➝ Buy$30.70High
11/3/2020Morgan StanleyUpgradeEqual Weight ➝ OverweightLow
9/30/2020Atlantic SecuritiesInitiated CoverageNeutral$105.00Low
8/25/2020Stifel NicolausLower TargetHold$39.00 ➝ $37.00Low
8/19/2020Bank of AmericaBoost TargetNeutral$99.00 ➝ $103.00Low
8/19/2020Stifel NicolausBoost TargetHold$85.00 ➝ $100.00Medium
8/19/2020Jefferies Financial GroupBoost TargetBuy$95.00 ➝ $110.00Medium
8/19/2020SVB LeerinkBoost TargetOutperform$95.00 ➝ $100.00High
8/19/2020Robert W. BairdBoost TargetOutperform$87.00 ➝ $104.00High
8/19/2020Needham & Company LLCReiterated RatingHoldHigh
8/19/2020CitigroupBoost TargetNeutral$85.00 ➝ $100.00High
8/19/2020Wells Fargo & CompanyReiterated RatingOverweight$100.00 ➝ $105.00High
7/27/2020Credit Suisse GroupBoost TargetNeutral$53.00 ➝ $54.00Medium
7/20/2020Bank of AmericaBoost TargetNeutral$88.00 ➝ $99.00High
7/13/2020The Goldman Sachs GroupInitiated CoverageNeutralHigh
7/1/2020The Goldman Sachs GroupReiterated RatingBuy ➝ NeutralMedium
5/22/2020CfraLower TargetHold$89.00 ➝ $85.00Low
5/22/2020Bank of AmericaBoost TargetNeutral$74.00 ➝ $88.00Low
5/22/2020UBS GroupBoost TargetNeutral$84.00 ➝ $87.00Medium
5/22/2020CowenBoost TargetOutperform$80.00 ➝ $95.00Medium
5/22/2020Wells Fargo & CompanyBoost TargetOverweight$82.00 ➝ $95.00Low
5/22/2020SVB LeerinkBoost TargetOutperform$90.00 ➝ $95.00Low
4/28/2020Royal Bank of CanadaInitiated CoverageSector PerformLow
4/28/2020UBS GroupLower TargetNeutral$90.00 ➝ $84.00Low
4/16/2020SunTrust BanksLower TargetHold$90.00 ➝ $75.00Low
4/2/2020Stifel NicolausLower TargetHold$85.00 ➝ $73.00Medium
3/30/2020Wells Fargo & CompanyLower TargetOverweight$100.00 ➝ $82.00Low
3/26/2020BarclaysLower TargetEqual Weight$85.00 ➝ $76.00Low
3/20/2020CitigroupLower TargetNeutral$85.00 ➝ $75.00Medium
2/24/2020Needham & Company LLCDowngradeBuy ➝ Hold$85.00High
2/21/2020CfraLower TargetHold$60.00 ➝ $57.00Low
2/19/2020Piper SandlerBoost TargetOverweight$86.00 ➝ $96.00Medium
2/19/2020UBS GroupBoost TargetBuy ➝ Neutral$87.00 ➝ $90.00High
2/12/2020HSBCUpgradeHold ➝ BuyLow
1/28/2020UBS GroupReiterated RatingBuyLow
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$100.00 ➝ $100.00Medium
1/6/2020CitigroupInitiated CoverageNeutral$85.00Low
1/3/2020Needham & Company LLCInitiated CoverageBuy$77.00Medium
11/26/2019UBS GroupBoost TargetNeutral$82.00 ➝ $87.00Low
11/26/2019JPMorgan Chase & Co.Boost TargetOverweight$85.00 ➝ $90.00High
11/26/2019Needham & Company LLCReiterated RatingBuy$92.00 ➝ $85.00High
11/14/2019Stifel NicolausInitiated CoverageHold$85.00High
10/18/2019UBS GroupDowngradeBuy ➝ Neutral$82.00Medium
10/9/2019BarclaysLower TargetEqual Weight$78.00 ➝ $76.00Low
8/19/2019Needham & Company LLCBoost TargetBuy$92.00Low
8/15/2019Robert W. BairdReiterated RatingOutperform$79.00 ➝ $82.00High
8/15/2019Piper Jaffray CompaniesBoost TargetOverweight$83.00 ➝ $86.00High
7/16/2019Bank of AmericaDowngradeBuy ➝ Neutral$76.00Low
7/15/2019BarclaysDowngradeOverweight ➝ Equal Weight$86.00 ➝ $78.00Low
6/11/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$83.00Low
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
5/15/2019Bank of AmericaLower TargetBuy$88.00 ➝ $82.00High
5/15/2019Deutsche Bank AktiengesellschaftLower TargetBuy$90.00 ➝ $85.00High
5/15/2019BarclaysLower TargetOverweight$88.00 ➝ $86.00High
3/26/2019CowenBoost TargetOutperform ➝ Outperform$80.00 ➝ $90.00Low
3/15/2019UBS GroupInitiated CoverageBuy ➝ Buy$92.00Low
2/25/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$77.00 ➝ $88.00Low
2/21/2019Janney Montgomery ScottReiterated RatingOverweight ➝ Buy$80.00 ➝ $90.00Low
2/21/2019Bank of AmericaReiterated RatingBuy ➝ Buy$78.00 ➝ $87.00Low
2/21/2019BarclaysBoost TargetOverweight ➝ Overweight$80.00 ➝ $83.00Low
2/21/2019Deutsche Bank AktiengesellschaftReiterated RatingBuy$90.00Low
2/21/2019JPMorgan Chase & Co.Boost TargetOverweight$85.00Medium
2/20/2019Robert W. BairdReiterated RatingBuy$77.00 ➝ $82.00High
2/12/2019Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$80.00 ➝ $85.00Low
1/2/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$77.00High
12/31/2018Alembic Global AdvisorsDowngradeHoldMedium
11/20/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$86.00 ➝ $89.00Medium
10/10/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$84.00 ➝ $86.00High
9/18/2018The Goldman Sachs GroupReiterated RatingBuy$77.00 ➝ $82.00Low
9/17/2018The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyLow
8/15/2018Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$77.00 ➝ $80.00Medium
8/15/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$83.00 ➝ $84.00Medium
5/15/2018CowenUpgradeMarket Perform ➝ OutperformHigh
4/11/2018Morgan StanleyLower TargetOverweight ➝ Overweight$95.00 ➝ $91.00Low
4/9/2018The Goldman Sachs GroupUpgradeNeutral ➝ BuyMedium
4/2/2018Morgan StanleyBoost TargetOverweight$90.00 ➝ $95.00High
2/15/2018JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$75.00 ➝ $80.00Low
1/18/2018Robert W. BairdReiterated RatingBuy$76.00Medium
1/8/2018BarclaysReiterated RatingBuy$74.00Low
1/3/2018Evercore ISIInitiated CoverageOutperform$75.00Medium
(Data available from 12/8/2017 forward)

News Sentiment Rating

0.56 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 7 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
5/12/2022
  • 15 very positive mentions
  • 44 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/11/2022
  • 9 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/11/2022
  • 8 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/10/2022
  • 14 very positive mentions
  • 38 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/9/2022
  • 11 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/9/2022
  • 14 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/8/2022
  • 25 very positive mentions
  • 50 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
12/8/2022

Current Sentiment

  • 25 very positive mentions
  • 50 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
Agilent Technologies logo
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $156.28
Low: $153.48
High: $156.99

50 Day Range

MA: $139.51
Low: $121.55
High: $156.96

52 Week Range

Now: $156.28
Low: $112.52
High: $162.62

Volume

1,289,896 shs

Average Volume

1,733,615 shs

Market Capitalization

$46.27 billion

P/E Ratio

37.48

Dividend Yield

0.55%

Beta

1.08

Frequently Asked Questions

What sell-side analysts currently cover shares of Agilent Technologies?

The following equities research analysts have issued stock ratings on Agilent Technologies in the last year: Bank of America Co., Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, Evercore ISI, Jefferies Financial Group Inc., KeyCorp, Robert W. Baird, Stifel Nicolaus, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for A.

What is the current price target for Agilent Technologies?

14 Wall Street analysts have set twelve-month price targets for Agilent Technologies in the last year. Their average twelve-month price target is $157.00, suggesting a possible upside of 0.5%. Robert W. Baird has the highest price target set, predicting A will reach $170.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $139.00 for Agilent Technologies in the next year.
View the latest price targets for A.

What is the current consensus analyst rating for Agilent Technologies?

Agilent Technologies currently has 4 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe A will outperform the market and that investors should add to their positions of Agilent Technologies.
View the latest ratings for A.

What other companies compete with Agilent Technologies?

How do I contact Agilent Technologies' investor relations team?

Agilent Technologies' physical mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company's listed phone number is (800) 227-9770 and its investor relations email address is [email protected] The official website for Agilent Technologies is www.agilent.com. Learn More about contacing Agilent Technologies investor relations.